ARVO recognizes Daniel R. Saban as a rising star in the world of ophthalmology and visual science
Leading research organization awards Associate Professor Daniel R. Saban (Ophthalmology, SOM) for his contributions to the field. Saban is commercializing this research through Duke University start-up Piximune Therapeutics.
Staff, Faculty and Retirees Invited to Duke Centennial Reception on May 16
Reception will feature music, refreshments and more – including the OTC Centennial Timeline, which displays Duke innovations and startups.
Duke Entrepreneurial Leaders Network Announces New Cohort
ELN, a select group of Duke alumni committed to founding or leading an innovation-driven startup, has announced its 2024 cohort.
Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer
Lumicell is an MIT start-up based on breast cancer imaging technology co-developed by Dr. David Kirsch (Radiation Oncology, SOM).
Oak Ridge National Laboratory Collaborates with IonQ to Drive Critical U.S. Infrastructure Improvements
ORNL will leverage Duke start-up IonQ’s quantum technology to help solve power grid challenges in the U.S.
Plug and Play Announces Inaugural Batch of Startups Selected for their Medtech Program
Duke start-up Sparta Biomedical has been selected for Batch 1 of Plug and Play's Warsaw Medtech program in Spring 2024.
The Power and Promise of RNA
Several Duke researchers studying RNA modification are profiled in this Magnify article from the School of Medicine. Tech available for licensing!
Duke Awarded Up to $33 Million to Develop OA Therapies that Rebuild Bone and Joints
OTC is participating with the Duke ARPA-H team, lead by Dr. Ben Alman (Chair of Orthopaedic Surgery, SOM), on all IP matters.
Transforming inventions into products: Duke charts a path for student innovators
Duke’s innovation ecosystem collaborates to offer Duke graduate and professional students a hands-on technology commercialization bootcamp – focused on student-led inventions.